PRaG5.0 combined with chemotherapy and sequential chemoimmunotherapy for massive SMARCA4-deficient undifferentiated tumor of the cervix: case report - Poll - MDSpire

PRaG5.0 combined with chemotherapy and sequential chemoimmunotherapy for massive SMARCA4-deficient undifferentiated tumor of the cervix: case report

  • By

  • Zixin Li

  • Xuezhou Pang

  • Zhongyao Wang

  • Jing Wen

  • Yanli Zhao

  • Daiyuan Ma

  • Jianquan Yang

  • May 8, 2026

  • 0 min

Share

Original Source(s)

PRaG5.0 combined with chemotherapy and sequential chemoimmunotherapy for massive SMARCA4-deficient undifferentiated tumor of the cervix: case report

  • by Zixin Li, Xuezhou Pang, Zhongyao Wang, Jing Wen, Yanli Zhao, Daiyuan Ma, Jianquan Yang

  • May 8, 2026

Related Content

Clinical benefit of paclitaxel/carboplatin plus bevacizumab with zoledronic acid in pulmonary epithelioid hemangioendothelioma complicated by hypertrophic pulmonary osteoarthropathy and cardiac tamponade: a case report

Use of PCSK9 Inhibitors Among Patients Receiving Immune Checkpoint Inhibitors for Cancer

Diffuse large B-cell lymphoma presenting as a scalp tumor with skull destruction and neurological symptoms: a case report